デフォルト表紙
市場調査レポート
商品コード
1409445

胃軸捻転治療の世界市場レポート 2024年

Gastric Volvulus Treatment Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
胃軸捻転治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

胃軸捻転治療市場規模は近年力強く成長しています。2023年の256億米ドルから2024年には271億8,000万米ドルへと、CAGR6.2%で拡大します。過去の期間に見られた成長は、手術技術の進歩、診断技術の強化、認知度や教育の向上、低侵襲手術の採用増加、調査や臨床研究の影響などの要因によるものです。

2023年の胃捻転市場は北米が最大地域でした。胃軸捻転治療市場レポートでは、アジア太平洋が予測期間中に最も急成長する地域となる見込みです。胃軸捻転治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 胃軸捻転治療市場の特徴

第3章 胃軸捻転治療市場の動向と戦略

第4章 胃軸捻転治療市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の胃軸捻転治療市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 胃軸捻転治療市場セグメンテーション

  • 世界の胃軸捻転治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 器官軸性軸捻転
  • 腸間軸軸捻転症
  • 世界の胃軸捻転治療市場、治療タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬剤
  • 手術
  • 世界の胃軸捻転治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • 世界の胃軸捻転治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • 世界の胃軸捻転治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • ホームケア
  • 専門クリニック
  • その他のエンドユーザー

第7章 胃軸捻転治療市場の地域および国分析

  • 世界の胃軸捻転治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の胃軸捻転治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の胃軸捻転治療市場

第9章 中国の胃軸捻転治療市場

第10章 インドの胃軸捻転治療市場

第11章 日本の胃軸捻転治療市場

第12章 オーストラリアの胃軸捻転治療市場

第13章 インドネシアの胃軸捻転治療市場

第14章 韓国の胃軸捻転治療市場

第15章 西欧の胃軸捻転治療市場

第16章 英国の胃軸捻転治療市場

第17章 ドイツの胃軸捻転治療市場

第18章 フランスの胃軸捻転治療市場

第19章 イタリアの胃軸捻転治療市場

第20章 スペインの胃軸捻転治療市場

第21章 東欧の胃軸捻転治療市場

第22章 ロシアの胃軸捻転治療市場

第23章 北米の胃軸捻転治療市場

第24章 米国の胃軸捻転治療市場

第25章 カナダの胃軸捻転治療市場

第26章 南米の胃軸捻転治療市場

第27章 ブラジルの胃軸捻転治療市場

第28章 中東の胃軸捻転治療市場

第29章 アフリカの胃軸捻転治療市場

第30章 胃軸捻転治療市場の競合情勢と企業プロファイル

  • 胃軸捻転治療市場の競合情勢
  • 胃軸捻転治療市場の企業プロファイル
    • PAI Pharma
    • Sun Pharmaceutical Industries Ltd.
    • ANI Pharmaceuticals Inc.
    • Fresenius SE and Co. KGaA
    • Mayne Pharma Group Limited

第31章 世界の胃軸捻転治療市場の競合ベンチマーキング

第32章 世界の胃軸捻転治療市場競争ダッシュボード

第33章 胃軸捻転治療市場における主要な合併と買収

第34章 胃軸捻転治療市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10983

“Gastric Volvulus Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric volvulus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric volvulus treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The gastric volvulus treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus
  • 2) By Treatment Type: Medication; Surgery
  • 3) By Route of Administration: Oral; Parenteral
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
  • 5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: PAI Pharma; Sun Pharmaceutical Industries Ltd.; ANI Pharmaceuticals Inc.; Fresenius SE and Co. KGaA; Mayne Pharma Group Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Gastric volvulus treatment involves surgical interventions, specifically focusing on volvulus reduction and the reintegration of the stomach into the abdominal cavity, especially in cases of intrathoracic migration. The treatment also addresses the correction of causal factors. Gastric volvulus surgery is typically a straightforward procedure, encompassing de-rotation, lowering of hernial contents into the abdominal wall, and repair of the hernial defect.

The main types of gastric volvulus treatment are organo-axial and mesentero-axial volvulus. Organo-axial volvulus occurs when the abdomen undergoes a 180-degree spin around its long axis, resulting in this condition. Treatment options include medication and surgery, with various routes of administration such as oral and parenteral. Distribution channels for these treatments include hospital pharmacies and retail pharmacies, serving purposes in hospitals, home healthcare, specialty clinics, and other healthcare settings.

The gastric volvulus treatment market research report is one of a series of new reports from. The Business Research Company that provides gastric volvulus treatment market statistics, including gastric volvulus treatment industry global market size, regional shares, competitors with a gastric volvulus treatment market share, detailed gastric volvulus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gastric volvulus treatment industry. This gastric volvulus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $25.6 billion in 2023 to $27.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be attributed to factors such as advancements in surgical techniques, enhanced diagnostic technologies, increased awareness and education, a rise in the adoption of minimally invasive procedures, and the influence of research and clinical studies.

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $34.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, the expanding geriatric population, the development of customized treatment plans, and the adoption of advanced imaging techniques. Major trends expected in the forecast period include the continued prominence of minimally invasive surgical techniques, a focus on awareness and early intervention, ongoing research in treatment modalities, the promotion of collaborative medical practices, and the increasing prevalence of customized treatment approaches.

The anticipated growth in the geriatric population is poised to drive the expansion of the gastric volvulus treatment market in the foreseeable future. The term 'geriatric population' pertains to individuals aged 65 and beyond, who are susceptible to various illnesses due to compromised immunity and advancing age. As gastric volvulus tends to occur in individuals over 50, the increasing number of elderly individuals is expected to be a significant factor propelling the market. According to America's Health Rankings in November 2022, the United States had over 55.8 million people aged 65 and above in 2021, constituting nearly 16.8% of the total population. Consequently, the growing geriatric population is a driving force behind the gastric volvulus treatment market.

The escalating incidence of gastrointestinal diseases is projected to be a key driver for the growth of the gastric volvulus treatment market in the coming years. Gastrointestinal diseases encompass a range of medical conditions affecting the internal structures of the gastrointestinal (GI) tract, including gastritis, inflammatory bowel disease, and gastric cancer. The holistic care provided during the treatment of gastric volvulus may involve strategies and considerations contributing to the overall health of the gastrointestinal system and its associated disorders. For example, as per Cancer Australia's data in September 2022, the projected number of new stomach cancer cases in Australia for 2022 is 2,572. This underscores the need for effective treatments in the face of increasing gastrointestinal diseases. Hence, the rising incidence of gastrointestinal diseases is a driving factor for the gastric volvulus treatment market.

Product innovations emerge as a prominent trend gaining traction in the gastric volvulus treatment market. Major companies in the market are introducing innovative products to maintain their competitive positions. For instance, in October 2023, Pfizer Inc., a pharmaceutical company based in the United States, announced the FDA approval of VELSIPITY (etrasimod) for people with moderate to severe active ulcerative colitis. This once-daily oral sphingosine-1-phosphate (S1P) receptor activator offers a positive benefit-risk profile, providing adults with an effective, steroid-free resolution through a convenient oral pill.

Companies operating in the gastric volvulus treatment market are focusing on product innovations such as digital radiology solutions to enhance radiologists' efficiency. A digital radiology solution involves leveraging digital technology in medical imaging for visualizing internal body structures and aiding in the diagnosis and management of conditions such as gastric volvulus through digital image capture and analysis. For instance, in February 2023, Carestream Health India Pvt. Ltd. launched the DRX Compass, a digital radiological solution designed for accuracy, convenience, and customization. This innovative solution empowers radiologists with heightened productivity and flexibility in configuring the system based on individual requirements.

In December 2021, Pfizer, a pharmaceutical and biotechnology corporation, acquired Arena Pharmaceuticals for $6.7 billion. This strategic acquisition aims to leverage Arena Pharmaceuticals' expertise in inflammation and immunology, contributing to Pfizer's innovation in developing potential therapies for patients dealing with immuno-inflammatory diseases, including gastrointestinal and dermatological conditions. Arena Pharmaceuticals is a U.S.-based company with a diverse portfolio of development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology.

Major companies operating in the gastric volvulus treatment market report are PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, Mylan N.V., GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc, ACROBiosystems Inc., Alomone Labs Ltd

North America was the largest region in the gastric volvulus market in 2023. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastric volvulus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric volvulus treatment market includes revenues earned by entities that perform laparotomy, gastric detorsion, and gastric fixation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Gastric Volvulus Treatment Market Characteristics

3. Gastric Volvulus Treatment Market Trends And Strategies

4. Gastric Volvulus Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Gastric Volvulus Treatment Market Size and Growth

  • 5.1. Global Gastric Volvulus Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gastric Volvulus Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gastric Volvulus Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastric Volvulus Treatment Market Segmentation

  • 6.1. Global Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Organo-Axial Volvulus
  • Mesentero-Axial Volvulus
  • 6.2. Global Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Surgery
  • 6.3. Global Gastric Volvulus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • 6.4. Global Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • 6.5. Global Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Gastric Volvulus Treatment Market Regional And Country Analysis

  • 7.1. Global Gastric Volvulus Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gastric Volvulus Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastric Volvulus Treatment Market

  • 8.1. Asia-Pacific Gastric Volvulus Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastric Volvulus Treatment Market

  • 9.1. China Gastric Volvulus Treatment Market Overview
  • 9.2. China Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastric Volvulus Treatment Market

  • 10.1. India Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastric Volvulus Treatment Market

  • 11.1. Japan Gastric Volvulus Treatment Market Overview
  • 11.2. Japan Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastric Volvulus Treatment Market

  • 12.1. Australia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastric Volvulus Treatment Market

  • 13.1. Indonesia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastric Volvulus Treatment Market

  • 14.1. South Korea Gastric Volvulus Treatment Market Overview
  • 14.2. South Korea Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastric Volvulus Treatment Market

  • 15.1. Western Europe Gastric Volvulus Treatment Market Overview
  • 15.2. Western Europe Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastric Volvulus Treatment Market

  • 16.1. UK Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastric Volvulus Treatment Market

  • 17.1. Germany Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastric Volvulus Treatment Market

  • 18.1. France Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastric Volvulus Treatment Market

  • 19.1. Italy Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastric Volvulus Treatment Market

  • 20.1. Spain Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastric Volvulus Treatment Market

  • 21.1. Eastern Europe Gastric Volvulus Treatment Market Overview
  • 21.2. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastric Volvulus Treatment Market

  • 22.1. Russia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastric Volvulus Treatment Market

  • 23.1. North America Gastric Volvulus Treatment Market Overview
  • 23.2. North America Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastric Volvulus Treatment Market

  • 24.1. USA Gastric Volvulus Treatment Market Overview
  • 24.2. USA Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastric Volvulus Treatment Market

  • 25.1. Canada Gastric Volvulus Treatment Market Overview
  • 25.2. Canada Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastric Volvulus Treatment Market

  • 26.1. South America Gastric Volvulus Treatment Market Overview
  • 26.2. South America Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastric Volvulus Treatment Market

  • 27.1. Brazil Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastric Volvulus Treatment Market

  • 28.1. Middle East Gastric Volvulus Treatment Market Overview
  • 28.2. Middle East Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastric Volvulus Treatment Market

  • 29.1. Africa Gastric Volvulus Treatment Market Overview
  • 29.2. Africa Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastric Volvulus Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Gastric Volvulus Treatment Market Competitive Landscape
  • 30.2. Gastric Volvulus Treatment Market Company Profiles
    • 30.2.1. PAI Pharma
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sun Pharmaceutical Industries Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. ANI Pharmaceuticals Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Fresenius SE and Co. KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Mayne Pharma Group Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Gastric Volvulus Treatment Market Competitive Benchmarking

32. Global Gastric Volvulus Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

34. Gastric Volvulus Treatment Market Future Outlook and Potential Analysis

  • 34.1 Gastric Volvulus Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Gastric Volvulus Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Gastric Volvulus Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer